Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Health

Aclaris Therapeutics completes enrollment for Phase 2 atopic dermatitis trial

Aclaris Therapeutics (NASDAQ:ACRS) announced it has successfully completed patient enrollment for its Phase 2 clinical trial of bosakitug (ATI-045), an investigational treatment for patients suffering from moderate-to-severe atopic dermatitis.

Leia mais: Aclaris Therapeutics completes enrollment for Phase 2 atopic dermatitis trial
Bloomberg

European IPO Pipeline Remains Robust, Goldman Sachs Says

Andre Kelleners, co-head of EMEA investment banking at Goldman Sachs, discusses the impact of the war in Iran on markets and M&A deals, saying clients "remain quiet forward leaning," while the majority of them "expects to do more this year than last year in M&A." Kelleners also discusses the pipeline of potential initial public offerings in Europe this year. "The pipeline for IPOs in Europe remains strong and remains robust."

Leia mais: European IPO Pipeline Remains Robust, Goldman Sachs Says
Bloomberg

Not Expecting Fed's Powell to Cut Rates, Schroders Says

David Rees, head of global economics at Schroders, discusses the impact of energy prices uncertainty on the Federal Reserve as the war in Iran continues. "If it is a relatively brief energy shock, I think you would look through that," he tells Bloomberg Television. He also discusses what to expect from Federal Reserve Chair Jerome Powell as the central bank prepares to deliver its interest rate decision on Wednesday. "I don't see him cutting rates. I think he's kind of backed away from that now," Rees adds.

Leia mais: Not Expecting Fed's Powell to Cut Rates, Schroders Says